Blog
RSS FeedPosted by Michael Wonder on 02 Dec 2023
Keytruda is a step closer to being available for more cancers listed on the PBS
1 December 2023 - Thousands of cancer patients in Australia will benefit from a major change that would see Keytruda offered ...
Posted by Michael Wonder on 01 Dec 2023
Insulin users beware: your Medicare drug plan may drop your insulin. What it means for you.
30 November 2023 - With Medicare annual open enrolment about to close on 7 December, Medicare experts are discovering many ...
Posted by Michael Wonder on 01 Dec 2023
New frontier will lead to better health outcomes
30 November 2023 - The Government has today tabled its response to an inquiry considering how to give Australian patients timely ...
Posted by Michael Wonder on 30 Nov 2023
Schedule of Pharmaceutical Benefits - 1 December 2023
1 December 2023 - The December 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Nov 2023
New Zealand Pharmaceutical Schedule - 1 December 2023
1 December 2023 - The December 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Nov 2023
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study
27 November 2023 - Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a ...
Posted by Michael Wonder on 29 Nov 2023
Patients on edge as drug price bargaining for Braftovi prolongs
28 November 2023 - Health insurance coverage for the colon cancer drug Braftovi (encorafenib) is unlikely to be available this ...
Posted by Michael Wonder on 26 Nov 2023
Xtandi to get expanded coverage for metastatic hormone sensitive prostate cancer next month
31 October 2023 - Prostate cancer drug Xtandi (enzalutamide), in combination with androgen deprivation therapy to treat patients with metastatic ...
Posted by Michael Wonder on 26 Nov 2023
‘Verzenio, a ray of hope for breast cancer patients, should get insurance benefits’
24 November 2023 - A petition has been posted to call for providing insurance benefits for Lilly's CDK 4/6 inhibitor ...
Posted by Michael Wonder on 25 Nov 2023
Coverage for emerging technologies - bridging regulatory approval and patient access
25 November 2023 - A new pathway proposed by CMS aims to expedite access to breakthrough devices while preserving Medicare’s independent ...
Posted by Michael Wonder on 21 Nov 2023
Sandoz launches Hyrimoz (adalimumab) high concentration formulation in Europe, aiming to improve patient care
21 November 2023 - Hyrimoz HCF to launch progressively across Europe. ...
Posted by Michael Wonder on 21 Nov 2023
Funding verdict looms on ‘future of cancer therapy’
21 November 2023 - The chance of survival for hundreds of Australians living with a deadly type of blood cancer ...
Posted by Michael Wonder on 16 Nov 2023
New treatment for advanced prostate cancer added to the PBS
16 November 2023 - Prostate cancer is one of the most commonly diagnosed cancer in Australia. ...
Posted by Michael Wonder on 15 Nov 2023
AMA urges coverage of obesity treatments as payers balk at costs
13 November 2023 - The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments ...
Posted by Michael Wonder on 15 Nov 2023
More than 800 US counties are 'insulin deserts.' How these senators want to help Americans with diabetes.
14 November 2023 - Lacy McGee, 30, spent her last year of graduate school scouring Facebook groups and meeting strangers ...